Breast cancer as a systemic disease: a view of metastasis
Top Cited Papers
Open Access
- 31 July 2013
- journal article
- review article
- Published by Wiley in Journal of Internal Medicine
- Vol. 274 (2), 113-126
- https://doi.org/10.1111/joim.12084
Abstract
Breast cancer is now the most frequently diagnosed cancer and leading cause of cancer death in women worldwide. Strategies targeting the primary tumour have markedly improved, but systemic treatments to prevent metastasis are less effective; metastatic disease remains the underlying cause of death in the majority of patients with breast cancer who succumb to their disease. The long latency period between initial treatment and eventual recurrence in some patients suggests that a tumour may both alter and respond to the host systemic environment to facilitate and sustain disease progression. Results from studies in animal models suggest that specific subtypes of breast cancer may direct metastasis through recruitment and activation of haematopoietic cells. In this review, we focus on data implicating breast cancer as a systemic disease.Keywords
Funding Information
- Harvard Stem Cell Institute (NIH RO1 CA166284-01)
This publication has 82 references indexed in Scilit:
- Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab eraThe Breast, 2013
- Prognostic Value of Circulating Tumor Cells According to Immunohistochemically Defined Molecular Subtypes in Advanced Breast CancerClinical Breast Cancer, 2012
- Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patientsBritish Journal of Cancer, 2012
- Aspirin and cancer risk: a quantitative review to 2011Annals of Oncology, 2012
- The dynamic change of circulating tumour cells in patients with operable breast cancer before and after chemotherapy based on a multimarker QPCR platformBritish Journal of Cancer, 2012
- Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patientsArchiv für Gynäkologie, 2011
- Detection of minimal residual disease in blood and bone marrow in early stage breast cancerCancer, 2010
- Concordance of clinical and molecular breast cancer subtyping in the context of preoperative chemotherapy responseBreast Cancer Research and Treatment, 2009
- Systemic Spread Is an Early Step in Breast CancerCancer Cell, 2008
- Osteopontin overexpression in breast cancer: Knowledge gained and possible implications for clinical managementJournal of Cellular Biochemistry, 2007